Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis B vaccine (Massachusetts General Hospital)
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
A recombinant protein subunit vaccine consisting of the hepatitis B surface antigen (HBsAg), used for active immunization to prevent infection caused by all known subtypes of the hepatitis B virus (HBV). In the context of a clinical trial (NCT02057263) conducted by Massachusetts General Hospital, this standard vaccine was evaluated in healthy adults aged 40-70 to determine if the bisphosphonate medication alendronate could serve as an adjuvant to enhance the humoral immune response. The vaccine works by stimulating the immune system to produce neutralizing antibodies (anti-HBs) against the viral surface antigen, providing long-term protection against the pathogen.
- Brand names
- Sci-B-VacEngerix-B
- Other names
- Hepatitis B Vaccine (Recombinant)HBsAg vaccineRecombinant Hepatitis B Surface Antigen Vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on hepatitis B vaccine (Massachusetts General Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis B vaccine (Massachusetts General Hospital).